Denali Therapeutics Inc (NASDAQ:DNLI)
| 30.43 Delayed Data As of 4:00pm ET |  -1.09 / -3.46%Today’s Change | 20.76 Today|||52-Week Range 39.43 | +9.42% Year-to-Date |
Latest DNLI News | Press Releases
No recent news for Denali Therapeutics Inc.
Today’s Trading
| Previous close | 31.52 |
| Today’s open | 30.91 |
| Day’s range | 30.35 - 31.57 |
| Volume | 16,350 |
| Average volume (3 months) | 721,999 |
| Market cap | $4.3B |
Data as of 4:00pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | -8.61% |
| Earnings growth (this year) | -20.38% |
| Earnings growth (next 5 years) | -11.13% |
| Revenue growth (last year) | +122.90% |
| P/E ratio | NM |
| Price/Sales | 32.19 |
| Price/Book | 4.11 |
Competitors
Data as of 3:59pm ET, 06/05/2023
Financials
| Next reporting date | August 2, 2023 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $108.5M |
| Annual profit (last year) | -$326.0M |
| Net profit margin | -300.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
